Skip to main content
. 2021 Apr 1;12:665322. doi: 10.3389/fimmu.2021.665322

Table 5.

Distribution of major autoimmune diseases among different categories/types of PIDs.

Category/type of PIDs Number of patients Autoimmune Cytopenia(%) IBD(%) CD(%) Endocrine disease(%) Skin(%)
Immunodeficiencies affecting cellular and humoral immunity 78 17.9 2.6 2.6 1.3 10.3
SCID 14 14.3 0 0 0 0
OS 6 50.0 0 0 0 100
Leaky SCID 9 33.3 0 0 0 11.1
bona fide CID 49 12.2 4.1 4.1 2.0 2.0
Combined immunodeficiencies with associated or syndromic features 28 17.9 0 3.6 3.6 0
Wiskott–Aldrich syndrome 6 33.3 0 16.7 0 0
DiGeorge syndrome 4 25.0 0 0 0 0
Ataxia telangiectasia 6 0 0 0 0 0
Hyper-IgE syndrome 7 0 0 0 0 0
Other CID with syndromic features 5 40 0 0 20 0
Predominantly antibody deficiencies 83 8.4 7.2 2.4 1.2 1.2
Agammaglobulinemia 14 0 0 0 0 0
CVID 42 11.9 9.5 4.8 0 2.4
Other antibody deficiencies 27 7.4 7.4 0 3.7 0
Diseases of immune dysregulation 20 20.0 40.0 5.0 20.0 5.0
ALPS (Fas deficiency) 3 100 0 0 0 0
IPEX syndrome 1 100 0 0 100 0
LRBA deficiency 1 0 0 0 0 0
Immune dysregulation
with colis
6 0 100 0 0 16.7
Familial hemophagocytic
lymphohistiocytosis
3 0 0 0 0 0
Chediak Higashi 2 0 0 0 0 0
Other diseases of immune dysregulation 4 0 50 25 75 0
Congenital defects of phagocyte number or function 9 11.1 22.2 0 11.1 0
CGD 4 0 50.0 0 25.0 0
Congenital neutropenia 3 33.3 0 0 0 0
Other phagocytic defects 2 0 0 0 0 0
Defects of intrinsic and innate immunity 6 0 0 0 16.7 0
STAT1 GOF 2 0 0 0 50 0
MSMD 4 0 0 0 0 0
Complement deficiencies 68 0 0 2.9 0 0
HAE/C1-inhibitor deficiency 55 0 0 3.6 0 0
Other complement deficiencies 13 0 0 0 0 0

ALPS, autoimmune lymphoproliferative syndrome; CD, celiac disease; CGD, chronic granulomatous disease; CID, combined immunodeficiency; CVID, common variable immunodeficiency; GOF, gain-of-function; HAE, hereditary angioedema; IBD, inflammatory bowel disease; IPEX, immune dysfunction, polyendocrinopathy, enteropathy, LRBA, lipopolysaccharide-responsive and beige-like anchor protein; MSMD, mendelian susceptibility to mycobacterial disease; OS, Omenn Syndrome; PID, primary immunodeficiency disease; SCID, severe combined immunodeficiency; STAT, signal transducer and activator of transcription.